
With rising medical requirements worldwide, increasing research and development (R&D) efforts, and acceptance of the newest digital technologies, the pharmaceutical sector is well-positioned for significant growth and profitability in the future years.
Given the industry’s bright growth prospects, fundamentally sound pharma stocks Merck & Co., Inc. (MRK), Collegium Pharmaceutical, Inc. (COLL) and Johnson & Johnson (JNJ) could be ideal investments for last-minute year-end profits.